Department of Head and Neck Surgery, Linyi Cancer Hospital, Linyi, China.
Eur Rev Med Pharmacol Sci. 2022 Jul;26(14):4947. doi: 10.26355/eurrev_202207_29277.
The article "METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2, by Q.-Z. Meng, C.-H. Cong, X.-J. Li, F. Zhu, X. Zhao, F.-W. Chen, published in Eur Rev Med Pharmacol Sci 2020; 24 (8): 4328-4336-DOI: 10.26355/eurrev_202004_21014-PMID: 32373970" has been retracted by the authors. After publication, several issues were raised on PubPeer about the reliability of the published results. The same authors stated that the study was not performed in accordance with the standard procedures required. In particular, Figure 1 also presents some concerns as it does not reflect the experimental data reported in the study. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/21014.
该文“METTL3 通过介导 EZH2 的 M6A 修饰促进鼻咽癌的进展，作者：孟庆智，丛超，李雪静，朱芳，赵勋，陈奋威，发表于 2020 年《欧洲评论医学与药理学科学》24（8）：4328-4336-DOI：10.26355/eurrev_202004_21014-PMID：32373970”已被作者撤回。发表后，PubPeer 上就已发布结果的可靠性提出了一些问题。同一作者表示，该研究未按照所需的标准程序进行。特别是，图 1 也存在一些问题，因为它不能反映研究中报告的实验数据。出版商对由此造成的任何不便表示歉意。https://www.europeanreview.org/article/21014.
